TerminatedPhase 2

Self-Propelled Percutaneous Endoscopic GastroJejunostomy (PEG-J)

Stopped: Proof of principle was achieved after inclusion of 7 patients

United States7 participantsStarted 2012-01

Plain-language summary

This research is being done to study the safety of an investigational percutaneous endoscopic gastrojejunostomy (PEGJ) tube and whether the addition of a balloon on the end of the J tube prevents it from slipping back into the stomach.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age 18-90 years * need for post-pyloric feeding (patients unable to eat due to stroke, intubated patients with respiratory failure, patients with acute pancreatitis, etc) * ability to give informed consent for the study Exclusion Criteria: * patients with uncorrectable bleeding disorders (INR more than 1.5, platelet count less than 50,000) * inability to get informed consent for the study from patients or their families * pregnancy (all women of child-bearing age will undergo urine pregnancy testing)

What they're measuring

Safety: Number of Participants With Adverse Events

Timeframe: From date of PEGJ placement up to 3 weeks

Trial details

NCT IDNCT01551095

SponsorJohns Hopkins University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-05

Results submitted2016-08-21

View on ClinicalTrials.gov More GERD trials